|
|
|
Home > In Vitro Diagnostics |
|
|
|
|
In Vitro Diagnostics Market Research Reports |
Protein Electrophoresis: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Protein Electrophoresis testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
|
|
|
|
AFP: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of AFP testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
|
|
|
|
CA 15-3/27-29: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of CA 15-3/27-29 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
|
|
|
|
CA 19-9: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of CA 19-9 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
|
|
|
|
CEA: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of CEA testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
|
|
|
|
Ferritin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Ferritin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
|
|
|
|
Follate (Folic Acid): 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Follate (Folic Acid) testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
|
|
|
|
Glycosylated Hemoglobin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Glycosylated Hemoglobin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
|
|
|
|
25-Hydroxy Vitamin D2 and D3: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of 25-Hydroxy Vitamin D2 and D3 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
|
|
|
|
Occult Blood: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Occult Blood testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
|
|
|
|
PAP: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of PAP testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
|
|
|
|
PSA: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of PSA testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
|
|
|
|
Thyroglobulin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Thyroglobulin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
|
|
|
|
Vitamin B-12: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Vitamin B-12 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
|
|
|
|
Amphetamines: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Amphetamines testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
|
|
|
|
Barbiturates: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Barbiturates testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
|
|
|
|
Benzodiazepines: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Benzodiazepines testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
|
|
|
|
Cannabinoids/Marijuana: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Cannabinoids/Marijuana testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
|
|
|
|
|